# Transposon Therapeutics

**Canonical:** https://apis.io/providers/transposon-therapeutics/  
**Website:** https://transposonrx.com  
**APIs profiled:** 0

Transposon Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformational therapies for neurodegenerative and aging-related diseases driven by LINE-1 retrotransposon activity. Its lead asset, TPN-101 (censavudine), is a potent oral inhibitor of LINE-1 reverse transcriptase in late-stage development for progressive supranuclear palsy (PSP), amyotrophic lateral sclerosis (ALS) / frontotemporal dementia (FTD), and Alzheimer's disease. The pipeline also includes follow-on novel nucleoside reverse transcriptase inhibitors (NRTIs) and Protein Kinase R inhibitors (PKRi) targeting pathways activated by LINE-1 and implicated in cognitive impairment. Surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network; enrichment found a corporate marketing website only and no public API, developer, or machine-readable surface.

## Kin Score — 10.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Transposon Therapeutics Domain Security** — TLSv1.2 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Neurodegeneration, Clinical Stage, Drug Development, Life Sciences, Neuroscience

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/transposon-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.